Robert E Landry Regeneron Pharmaceuticals, Inc. (REGN) insider trading activity

REGN Quotes by TradingView

Robert E Landry is EVP Finance CFO of REGENERON PHARMACEUTICALS, INC.. Currently has a direct ownership of 23,693 shares of REGN, which is worth approximately $16.6 Million. The most recent transaction as insider was on Feb 02, 2024, when has been sold 281 shares (Common Stock) at a price of $956.65 per share, resulting in proceeds of $268,818. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 23.7K
0% 3M change
8.65% 12M change
Total Value Held $16.6 Million

Robert E Landry Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 02 2024
SELL
Payment of exercise price or tax liability
$268,818 $956.65 p/Share
281 Reduced 1.17%
23,693 Common Stock
Feb 02 2024
BUY
Exercise of conversion of derivative security
$151,592 $378.98 p/Share
400 Added 1.64%
23,974 Common Stock
Jan 31 2024
SELL
Payment of exercise price or tax liability
$268,864 $953.42 p/Share
282 Reduced 1.18%
23,574 Common Stock
Jan 31 2024
BUY
Exercise of conversion of derivative security
$151,592 $378.98 p/Share
400 Added 1.65%
23,856 Common Stock
Jan 24 2024
SELL
Payment of exercise price or tax liability
$334,843 $951.26 p/Share
352 Reduced 1.48%
23,456 Common Stock
Jan 24 2024
BUY
Exercise of conversion of derivative security
$189,490 $378.98 p/Share
500 Added 2.06%
23,808 Common Stock
Jan 23 2024
SELL
Payment of exercise price or tax liability
$736,036 $948.5 p/Share
776 Reduced 3.22%
23,308 Common Stock
Jan 23 2024
BUY
Exercise of conversion of derivative security
$416,878 $378.98 p/Share
1,100 Added 4.37%
24,084 Common Stock
Jan 17 2024
SELL
Payment of exercise price or tax liability
$330,048 $932.34 p/Share
354 Reduced 1.52%
22,984 Common Stock
Jan 17 2024
BUY
Exercise of conversion of derivative security
$189,490 $378.98 p/Share
500 Added 2.1%
23,338 Common Stock
Jan 12 2024
SELL
Payment of exercise price or tax liability
$527,206 $928.18 p/Share
568 Reduced 2.43%
22,838 Common Stock
Jan 12 2024
BUY
Exercise of conversion of derivative security
$303,184 $378.98 p/Share
800 Added 3.3%
23,406 Common Stock
Jan 04 2024
SELL
Payment of exercise price or tax liability
$313,631 $917.05 p/Share
342 Reduced 1.49%
22,606 Common Stock
Jan 04 2024
BUY
Exercise of conversion of derivative security
$189,490 $378.98 p/Share
500 Added 2.13%
22,948 Common Stock
Jan 03 2024
SELL
Payment of exercise price or tax liability
$627,662 $912.3 p/Share
688 Reduced 2.97%
22,448 Common Stock
Jan 03 2024
BUY
Exercise of conversion of derivative security
$416,878 $378.98 p/Share
1,100 Added 4.54%
23,136 Common Stock
Jan 02 2024
SELL
Payment of exercise price or tax liability
$373,991 $888.34 p/Share
421 Reduced 1.87%
22,036 Common Stock
Jan 02 2024
BUY
Exercise of conversion of derivative security
$246,337 $378.98 p/Share
650 Added 2.81%
22,457 Common Stock
Dec 28 2023
SELL
Payment of exercise price or tax liability
$541,546 $884.88 p/Share
612 Reduced 2.73%
21,807 Common Stock
Dec 28 2023
BUY
Exercise of conversion of derivative security
$322,133 $378.98 p/Share
850 Added 3.65%
22,419 Common Stock
Dec 27 2023
SELL
Payment of exercise price or tax liability
$472,737 $872.21 p/Share
542 Reduced 2.45%
21,569 Common Stock
Dec 27 2023
BUY
Exercise of conversion of derivative security
$284,235 $378.98 p/Share
750 Added 3.28%
22,111 Common Stock
Dec 13 2023
SELL
Payment of exercise price or tax liability
$629,819 $871.12 p/Share
723 Reduced 3.27%
21,361 Common Stock
Dec 13 2023
BUY
Exercise of conversion of derivative security
$378,980 $378.98 p/Share
1,000 Added 4.33%
22,084 Common Stock
Dec 12 2023
SELL
Payment of exercise price or tax liability
$5,466,666 $856.71 p/Share
6,381 Reduced 23.23%
21,084 Common Stock
REL

Robert E Landry

EVP Finance CFO
Tarrytown, NY

Track Institutional and Insider Activities on REGN

Follow REGENERON PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells REGN shares.

Notify only if

Insider Trading

Get notified when an Regeneron Pharmaceuticals, Inc. insider buys or sells REGN shares.

Notify only if

News

Receive news related to REGENERON PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on REGN